Colossal Biosciences CEO on De-Extinction, Dire Wolves, and Human Healthcare Applications

De-Extinction and Species Preservation

• 💡 Colossal Biosciences is the world's first de-extinction and species preservation company, utilizing ancient DNA, genome engineering (like CRISPR), and advanced reproductive technologies.
• 🎯 Their work aims to bring back extinct species, support modern conservation efforts, and inspire future scientists.
• 🚀 The company has successfully cloned red wolves and created woolly mice with traits similar to woolly mammoths, with the ultimate goal of reviving the woolly mammoth.

Dire Wolf Revival and Conservation

• 🐺 The company is actively working on bringing back dire wolves through genetic engineering, with the first specimens housed in a secure ecological preserve in the northern United States.
• ⚠️ The exact location is kept confidential due to past security concerns with public interest in their woolly mice.
• 🌍 De-extinction technologies can help make animals and plants more adaptive to changing climates and restore degraded ecosystems.

Applications in Human Healthcare

• 🧬 By studying ancient DNA and comparative genomics, Colossal develops technologies applicable to human healthcare, including gene therapies and cancer research.
• 🧩 Their ability to edit multiple genes simultaneously is a breakthrough for treating complex, multigenic diseases that single-gene editing methods cannot address.
• 📈 Advancements in de-extinction technologies directly translate to more available gene therapies for human conditions.

Scientific Limitations and Future Possibilities

• 🚫 It is not possible to bring back dinosaurs because DNA degrades too quickly over 65 million years; the oldest DNA used by Colossal is approximately 1.2 million years old.
• 🦕 Despite the impossibility, dinosaurs remain the most frequent request the company receives.